Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

5 treatments under study, led by Deferoxamine

Related Conditions

Often studied with 6 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

Trial Status

Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (1)

Showing 1 of 1 trials
NCT00000623CompletedPrimary

Thalassemia (Cooley's Anemia) Clinical Research Network (TCRN)

Showing all 1 trials

Research Network

Common Treatments

  • Deferoxamine1
  • Decitabine1
  • Arginine1
  • Deferiprone1
  • Sildenafil1

Active Sponsors

  • Carelon Research1
  • National Heart, Lung, and Blood Institute (NHLBI)1
  • Thalassemia Clinical Research Network1

Top Investigators

Related Conditions

  • Hematologic Diseases1
  • Hypertension Pulmonary1
  • Iron Overload1
  • Osteoporosis1
  • Thalassemia1

Activity Timeline